After 31 December 2025, your cloned UK trade marks and EU trade marks may no longer be valid if you…
Read More
Filter By
Identification of IP and signposting
Trade marks, copyright, designs, and patents – which do your clients really need? For many SME owners, intellectual property (IP)…
Read More
Biological sequencing: how inaccurate sequences can lead to a sequence of unfortunate events
Sequences are standardised representations of biological sequences, typically nucleotide (DNA/RNA) or amino acid (protein) sequences, that are included in patent…
Read More
No appeals without a party: EPO decides interveners cannot continue appeals alone
On 25 September 2025, the EPO’s Enlarged Board of Appeal (‘EBoA’) issued its decision in case G 2/24, the third…
Read More
Intellectual Property on the growth agenda – turning creative assets into commercial advantage
For many SMEs, intellectual property (IP) is treated as a defensive measure – something to protect against theft or infringement….
Read More
The cost of doing nothing – how ignoring Intellectual Property protection can erase years of hard work
When you’ve helped a client build a thriving business, the last thing you want to see is their success unravel,…
Read More
Intellectual Property: the most valuable asset missing from the balance sheet
Why Intellectual Property (IP) deserves a place in every SME’s strategic plan Ask most SME owners to list their most…
Read More
AI tools may not always be correct or confidential, so don’t use it for legal advice on your IP
In the context of intellectual property (IP), a hidden and potentially costly issue with using AI tools is confidentiality. This…
Read More
EPO confirms to Barker Brettell that they are making updates to the register to accept colour drawing as well as greyscale when an application is filed electronically from 1 October 2025
According to a recent exchange between Barker Brettell and The European Patent Office (EPO), it is about to modernise its…
Read More
Patenting antibodies in Europe and beyond: a comparative guide to the IP5
A Briefing Paper Antibodies and their derivatives, including bispecific and multispecific antibodies, fragments, and fusion products, have become central to…
Read More
How do I decide whether to opt out of the Unified Patent Court?
The Unified Patent Court (UPC) allows granted European patents to be enforced or challenged centrally and for a single ruling…
Read More
Why are SMEs failing to fully take advantage of Patent Box tax breaks?
On paper, changes in UK corporation tax have made Patent Box tax breaks increasingly attractive to SMEs, but recent statistics…
Read More